id: hyperglycemia_to_spinal_glial_activation
name: Hyperglycemia (Type I Diabetes) â†’ Spinal Glial Cell Hyperactivation
from_node:
  node_id: hyperglycemia
  node_name: Hyperglycemia (Type I Diabetes)
to_node:
  node_id: spinal_glial_activation
  node_name: Spinal Glial Cell Hyperactivation
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Chronic hyperglycemia and peripheral nerve damage trigger inflammatory
  signaling'
- 'Step 2: Inflammatory signals activate microglia in the spinal dorsal horn'
- 'Step 3: Microglial hyperactivation and increased astrocyte expression occur in
  central nervous system'
- 'Step 4: Central glial activation perpetuates neuropathic pain through neuroinflammation'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: K. Tseng et al. 2023. "Peripheral Nerve Denervation in Streptozotocin-Induced
    Diabetic Rats Is Reduced by Cilostazol." *Medicina*. https://doi.org/10.3390/medicina59030553
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.275228'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: cilostazol_treatment
  direction: weakens
  strength: strong
  description: Cilostazol administration suppressed microglial hyperactivation and
    modulated astrocyte expression, reducing central sensitization mechanisms underlying
    neuropathic pain
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/hyperglycemia_to_spinal_glial_activation.yaml
_category: biological
